It's Not Over For Teva Just Yet After J-Code Rejection, Citi Says By: Benzinga via Benzinga April 20, 2016 at 11:47 AM EDT The request by Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) for a separate J-code for Bendeka, the low-volume, ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR